The New Zealand mouse as a model for the therapy of human SLE: immunomodulation of murine lupus by sex hormones and cyclophosphamide.
D000728:Androgens / Q000627:therapeutic use*; D000818:Animals; D000906:Antibodies; D001665:Binding Sites; D003520:Cyclophosphamide / Q000627:therapeutic use*; D004247:DNA / Q000276:immunology; D004195:Disease Models, Animal; D005260:Female; D005921:Glomerulonephritis / Q000175:diagnosis / Q000401:mortality; D006801:Humans; D007074:Immunoglobulin G / Q000096:biosynthesis; D007075:Immunoglobulin M / Q000096:biosynthesis; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D008297:Male; D051379:Mice; D008814:Mice, Inbred NZB; D011061:Poly A / Q000276:immunology; D013947:Thymosin / Q000627:therapeutic use
D000728:Androgens; D000906:Antibodies; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D011061:Poly A; D013947:Thymosin; D003520:Cyclophosphamide; D004247:DNA